Coherus Biosciences Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.7M | 572 | 75.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $925,775 | 300 | 9.1% |
| Consulting Fee | $805,950 | 237 | 7.9% |
| Food and Beverage | $354,876 | 11,973 | 3.5% |
| Honoraria | $239,468 | 125 | 2.3% |
| Travel and Lodging | $150,859 | 587 | 1.5% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CHS170107 | $1.7M | 0 | 16 |
| CHS14209 | $1.6M | 0 | 4 |
| CHS-131-016 | $1.0M | 0 | 1 |
| SRF114-101 | $787,395 | 0 | 57 |
| A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma | $643,935 | 0 | 188 |
| CHS601 | $533,299 | 0 | 81 |
| A Phase 1/1b Study of CHS-388 (formerly known as SRF388) in Patients with Advanced Solid Tumors | $363,371 | 0 | 206 |
| 305 | $312,095 | 0 | 1 |
| CHS-1701-08 | $286,500 | 0 | 4 |
| CHS-131 | $220,086 | 0 | 1 |
| An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca (POEM) | $207,775 | 0 | 1 |
| CHS-1701-09 | $59,249 | 0 | 12 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Dilsher Dhoot, M.d, M.D | Retina Specialist | Santa Barbara, CA | $107,031 | $0 |
| Dr. Daniel Kiernan, Md, MD | Ophthalmology | Sarasota, FL | $82,085 | $0 |
| Seenu Hariprasad | Ophthalmology | Chicago, IL | $78,790 | $0 |
| Michael Singer, M.d, M.D | Ophthalmology | San Antonio, TX | $69,346 | $0 |
| Charina Toste, Apn, APN | Nurse Practitioner | Henderson, NV | $67,445 | $0 |
| Dr. Aron Kefela, Md, MD | Hematology & Oncology | Hiram, GA | $65,961 | $0 |
| Dr. Christos Mantzoros, Md, MD | Endocrinology, Diabetes & Metabolism | Boston, MA | $60,450 | $0 |
| Ms. Barbara Rogers, Crnp, CRNP | Registered Nurse | Philadelphia, PA | $48,303 | $0 |
| Ravindra Majeti, M.d, M.D | Hematology | Stanford, CA | $45,000 | $0 |
| Cynthia Simonson, Np, NP | Nurse Practitioner | Durham, NC | $38,981 | $0 |
| Rishi Singh, Md, MD | Ophthalmology | Boston, MA | $38,515 | $0 |
| Dr. Henry Hulter, M.d, M.D | Internal Medicine | San Rafael, CA | $37,750 | $0 |
| Ralph Boccia, M.d, M.D | Medical Oncology | Bethesda, MD | $37,465 | $0 |
| Fadi Braiteh, M.d, M.D | Internal Medicine | Las Vegas, NV | $36,140 | $0 |
| Dr. Krzysztof Misiukiewicz, Md, MD | Medical Oncology | New York, NY | $35,365 | $0 |
| Dr. Laura Wilson, M.d, M.D | Internal Medicine | Berkeley, CA | $35,060 | $0 |
| Panayiotis Savvides, Md, MD | Medical Oncology | Phoenix, AZ | $31,911 | $0 |
| Dr. Zujun Li, M.d, M.D | Medical Oncology | New York, NY | $25,584 | $0 |
| Dr. Ammar Sukari, M.d, M.D | Internal Medicine | Detroit, MI | $24,973 | $0 |
| Tarek Mekhail, M.d, M.D | Hematology & Oncology | Orlando, FL | $24,351 | $0 |
| Chaitali Nangia, Md, MD | Hematology & Oncology | Costa Mesa, CA | $23,844 | $0 |
| Dr. Daron Street, M.d, M.D | Gynecologic Oncology | Tulsa, OK | $22,645 | $0 |
| Mr. Kennon Mccollum, Msn, MSN | Nurse Practitioner | Stockbridge, GA | $20,825 | $0 |
| Dr. Shravan Kandula, M.d, M.D | Radiation Oncology | Orlando, FL | $20,381 | $0 |
| Dr. George Kim, M.d, M.D | Medical Oncology | Gainesville, FL | $19,308 | $0 |
About Coherus Biosciences Inc.
Coherus Biosciences Inc. has made $10.2M in payments to 5,259 healthcare providers, recorded across 13,794 transactions in the CMS Open Payments database. In 2024, the company paid $2.2M. The top product by payment volume is Udenyca ($2.7M).
Payments were distributed across 111 medical specialties. The top specialty by payment amount is Ophthalmology ($461,034 to 691 doctors).
Payment categories include: Food & Beverage ($354,876), Consulting ($805,950), Research ($7.7M), Travel & Lodging ($150,859).
Coherus Biosciences Inc. is associated with 3 products in the CMS Open Payments database.